Literature DB >> 1484528

Premorbid smoking, alcohol consumption, and coffee drinking habits in Parkinson's disease: a case-control study.

F J Jiménez-Jiménez1, D Mateo, S Giménez-Roldan.   

Abstract

A number of studies have reported lower cigarette consumption in patients with Parkinson's disease (PD) previous to onset of the disease. In an attempt to determine whether there existed a "premorbid attitude" by patients against the use of socially accepted "drugs," the premorbid tobacco, alcohol, and coffee consumption habits were compared in 128 PD patients and 256 controls. Patients and controls were selected by case control method and were recruited from the same health area and socioeconomic stratum. In males, the habits of smoking more than 10 cigarettes/day (p < 0.001) and drinking more than 50 g/day of alcohol (p < 0.001) were significantly less frequent in the PD patients than in the controls, but the differences in coffee consumption were nonsignificant. In females behavior did not differ significantly between the PD group and the controls for any of the three habits. There was no correlation between the amount of smoking and alcohol drinking and age at onset of PD or current Hoehn and Yahr's staging. Our results suggest the existence of a premorbid personality in males with PD, possibly conditioning a restrictive attitude toward the consumption of such toxic substances as tobacco and alcohol, yet a more tolerant attitude toward habits more widely accepted socially, like coffee consumption.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1484528     DOI: 10.1002/mds.870070407

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  25 in total

Review 1.  Parkinson's disease therapeutics: new developments and challenges since the introduction of levodopa.

Authors:  Yoland Smith; Thomas Wichmann; Stewart A Factor; Mahlon R DeLong
Journal:  Neuropsychopharmacology       Date:  2011-09-28       Impact factor: 7.853

2.  Non-genetic factors associated with the risk of Parkinson's disease in Iranian patients.

Authors:  N Hosseini Tabatabaei; B Babakhani; A Hosseini Tabatabaei; Z Vahabi; A Soltanzadeh
Journal:  Funct Neurol       Date:  2013 Apr-May

Review 3.  How far are we in understanding the cause of Parkinson's disease?

Authors:  Y Ben-Shlomo
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-07       Impact factor: 10.154

Review 4.  Impact of Coffee and Cacao Purine Metabolites on Neuroplasticity and Neurodegenerative Disease.

Authors:  Simonetta Camandola; Natalie Plick; Mark P Mattson
Journal:  Neurochem Res       Date:  2018-02-08       Impact factor: 3.996

Review 5.  Personality traits in patients with Parkinson's disease: assessment and clinical implications.

Authors:  Michele Poletti; Ubaldo Bonuccelli
Journal:  J Neurol       Date:  2011-11-15       Impact factor: 4.849

6.  Alcohol and risk of Parkinson's disease in a large, prospective cohort of men and women.

Authors:  Natalia Palacios; Xiang Gao; Eilis O'Reilly; Michael Schwarzschild; Marjorie L McCullough; Tinisha Mayo; Susan M Gapstur; Alberto A Ascherio
Journal:  Mov Disord       Date:  2012-06-19       Impact factor: 10.338

7.  Taste responses in patients with Parkinson's disease.

Authors:  H Sienkiewicz-Jarosz; A Scinska; W Kuran; D Ryglewicz; A Rogowski; E Wrobel; A Korkosz; A Kukwa; W Kostowski; P Bienkowski
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-01       Impact factor: 10.154

8.  Parkinson's disease and CYP1A2 activity.

Authors:  J T Forsyth; R A Grünewald; A Rostami-Hodjegan; M S Lennard; H J Sagar; G T Tucker
Journal:  Br J Clin Pharmacol       Date:  2000-10       Impact factor: 4.335

9.  Alcohol drinking and risk of Parkinson's disease: a case-control study in Japan.

Authors:  Wakaba Fukushima; Yoshihiro Miyake; Keiko Tanaka; Satoshi Sasaki; Chikako Kiyohara; Yoshio Tsuboi; Tatsuo Yamada; Tomoko Oeda; Takami Miki; Nobutoshi Kawamura; Nobutaka Sakae; Hidenao Fukuyama; Yoshio Hirota; Masaki Nagai
Journal:  BMC Neurol       Date:  2010-11-05       Impact factor: 2.474

10.  Genetic susceptibility loci, environmental exposures, and Parkinson's disease: a case-control study of gene-environment interactions.

Authors:  Sun Ju Chung; Sebastian M Armasu; Kari J Anderson; Joanna M Biernacka; Timothy G Lesnick; David N Rider; Julie M Cunningham; J Eric Ahlskog; Roberta Frigerio; Demetrius M Maraganore
Journal:  Parkinsonism Relat Disord       Date:  2013-03-16       Impact factor: 4.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.